Delayed developmental effects following prenatal exposure to drugs

Related Experiment Video

Updated: Oct 7, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

A Mantovani1, G Calamandrei

  • 1Gemma Calamandrei, Laboratory of Comparative Toxicology and Ecotoxicology and of Organ and System Pathophysiology, Istituto Superiore di Sanita, Rome, Italy. alberto@iss.it

Current Pharmaceutical Design
|May 29, 2001
PubMed

Insights

Prenatal exposure to certain chemicals can cause delayed health issues, particularly affecting the developing brain and kidneys. Understanding developmental biology and toxicity mechanisms is crucial for accurate risk assessment.

Area of Science:

  • Developmental Toxicology
  • Pharmacology
  • Neuroscience
  • Nephrology

Background:

  • Prenatal exposure to chemicals poses risks of delayed adverse effects.
  • Evaluating these effects is challenging for clinicians, epidemiologists, and toxicologists.
  • Nervous and excretory systems undergo critical development post-organogenesis, making them vulnerable to toxicants.

Purpose of the Study:

  • To review the effects of various drug classes on kidney and brain development following in utero exposure.
  • To highlight the importance of developmental biology and toxicity mechanisms in risk assessment.
  • To emphasize the need for functional development analysis in chemical safety evaluations.

Main Methods:

  • Literature review of studies on prenatal exposure to specific drug classes.
  • Analysis of effects on kidney histogenesis and function.
  • Analysis of effects on brain functional maturation and histogenesis.
  • Inclusion of data from human and animal studies.

Main Results:

  • Specific drug groups (aminoglycosides, ACE inhibitors, indomethacin) impact kidney development.
  • Other drug classes (anticonvulsants, antiretrovirals, benzodiazepines) affect brain development.
  • Delayed functional impairments can result from prenatal toxicant exposure.

Conclusions:

  • Adequate knowledge of developmental biology and toxicity mechanisms is vital for risk assessment.
  • Developmental toxicity studies must evaluate relevant drug targets.
  • Functional development analysis is essential for comprehensive chemical safety assessment.

More Related Videos

Construction of Vapor Chambers Used to Expose Mice to Alcohol During the Equivalent of all Three Trimesters of Human Development15:27

Construction of Vapor Chambers Used to Expose Mice to Alcohol During the Equivalent of all Three Trimesters of Human Development

Published on: July 13, 2014

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes05:13

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Published on: February 28, 2025

Related Concept Videos

Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Drug Toxicity: Overview01:00

Drug Toxicity: Overview

Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...